Patent Assignment
Reel/Frame 048080/0952
Release by Secured Party
Recorded: 2019-01-16
Pages: 11
Assignor
BANK OF AMERICA, N.A.
Executed: 2007-11-20
Assignees
REABLE THERAPEUTICS HOLDINGS LLC
1430 DECISION STREET, VISTA, CALIFORNIA, 92081
REABLE THERAPEUTICS FINANCE LLC
1430 DECISION STREET, VISTA, CALIFORNIA, 92081
Covered Properties
(51)
Hydratable Bioelectrode
Patent:
5,087,242 →
Application:
07/383,939 →
Iontophoretic Electrode with Solution Containment System
Patent:
5,037,380 →
Application:
07/572,477 →
Rehydratable Product and Method of Preparation Thereof
Patent:
5,236,412 →
Application:
07/627,714 →
Bioelectrode Seal
Patent:
5,248,295 →
Application:
07/703,456 →
Applicator for Electrophoretic Transcutaneous Delivery of Drugs
Patent:
343,684 →
Application:
07/851,825 →
Device for Generating an Electrical Voltage of Predetermined Waveform, Iontophoresis Apparatus for Transdermally Administering Medicinal Products and Electrical Stimulation Apparatus, Which Apparatuses Are Equipped with Such a Device
Patent:
5,426,387 →
Application:
08/016,269 →
Method of Making a Hydratable Bioelectrode
Patent:
5,281,287 →
Application:
08/031,260 →
Electrodes for Iontophoresis
Patent:
5,374,241 →
Application:
08/045,040 →
Transdermal Drug Delivery Device with Waveshape Generator
Patent:
5,499,967 →
Application:
08/181,078 →
Electrodes for Iontophoresis
Patent:
5,558,632 →
Application:
08/333,844 →
Hydration Assembly for Hydrating a Bioelectrode Element
Patent:
5,645,527 →
Application:
08/599,129 →
Reservoir Which Can Be Impregnated with a Solution of Active Principle, for an Iontophoretic Device for Transdermal Delivery of Medicinal Products and Method of Manufacture of Such a Resevoir
Patent:
5,718,913 →
Application:
08/600,916 →
Iontophoretic Delivery Device with Integral Hydrating Means
Patent:
5,730,716 →
Application:
08/711,816 →
Method and Device for Measuring the Quantity of an Active Principle Contained in a Reservoir
Patent:
5,889,396 →
Application:
08/737,445 →
Iontophoretic Delivery Device with Integral Hydrating Means
Patent:
6,223,075 →
Application:
08/762,051 →
Self-Contained Hydrating Systen and Iontophoresis Bioelectrode
Patent:
5,947,920 →
Application:
08/821,104 →
Ionophoretic Device for Transdermal Administration of Medicaments, and Disposable Assembly Forming Part of Such Device
Patent:
5,983,132 →
Application:
08/836,308 →
Iontophoretic Bioelectrode and Method of Using Same
Patent:
5,846,217 →
Application:
08/902,251 →
Device for Transcutaneous Administration of Medications Using Ionophoresis
Patent:
6,167,302 →
Application:
09/171,234 →
Nondeforming Electrode Connector
Patent:
6,062,915 →
Application:
09/244,734 →
Method for Measuring the Cutaneous Electrical Resistance of a Patient Subjected to Transdermal Administration of Medicine
Patent:
6,391,015 →
Application:
09/312,498 →
Methods and Apparatus for Ocular Iontophoresis
Patent:
6,319,240 →
Application:
09/318,181 →
Connection System for an Iontophoretic Drug Delivery Device
Patent:
6,687,536 →
Application:
09/458,239 →
Bioelectrode Having a Crushable Hydrating Assembly and Associated Method
Patent:
6,477,411 →
Application:
09/587,006 →
Ocular Iontophoretic Apparatus Handle
Patent:
6,728,573 →
Application:
09/599,245 →
High Current Density Iontophoretic Device and Method of Use Thereof
Patent:
6,546,283 →
Application:
09/691,411 →
Iontophoretic Electrode with Improved Current Distribution
Ocular Iontophoretic Device and Method for Inhibiting Vascular Endothelial Growth Factor (Vegf) Using the Same
Fluid Retention Assembly for an Iontophoretic Delivery Device and Associated Method for Preparing the Same
Ocular Iontophoretic Device and Method for Using the Same
Fluid Assembly Containing a Breaking Component for Release of Fluid and Method Therefore
Patent:
6,488,428 →
Application:
09/781,538 →
Electrode for the Transferring an Electric Current Through a Patient's Skin
Patent:
6,731,987 →
Application:
09/831,318 →
Ocular Iontophoretic Apparatus
Ocular Iontophoretic Apparatus Handle
Method and Device for the Iontophoretic Delivery of a Drug
Method and Device for the Iontophoretic Delivery of a Drug
Iontophoretic Power Supply
Iontophoretic Electrode
Methods for Treating Neoplastic, Angiogenic, Fibroblastic, and/or Immunosuppressive Ocular Irregularities via Administration of Methotrexate Based Medicaments, and Ocular Iontophoretic Devices for Delivering Methotrexate Based Medicament
Application:
10/707,793 →
Publication:
US 2005/0153969
The Use of 5-Fluorourcil, Delivered by Iontophoresis as an Inhibitor of Cell Proliferation in the Eye, Bulbar and Palpebral Conjunctiva, Eyelid, Peri-Orbital Soft Tissues and Skin
Application:
10/707,794 →
Publication:
US 2005/0153994
Improved Buffer Gel for Iontophoresis Electrodes
Application:
10/708,432 →
Publication:
US 2005/0197618
Apparatus for Electrotherapy Drug Delivery with Added Impurities
Ocular iontophoretic apparatus with handle
Application:
11/406,657 →
Publication:
US 2006/0189919
High-Side Current Regulator and Methods for Implementing a Multiple Channel Iontophoretic Device
Method and device for the iontophoretic delivery of a drug
Method and Device for the Iontophoretic Delivery of a Drug
Iontophoresis Apparatus and Method
Iontophoresis Apparatus and Method
Applicator for Ionophoretic Transcutaneous Delivery of Drugs
Patent:
359,805 →
Application:
29/020,223 →
Applicator for Ionophoretic Transcutaneous Delivery of Drugs
Patent:
359,806 →
Application:
29/020,224 →
Applicator for Ionophoretic Transcutaneous Delivery of Drugs
Patent:
359,807 →
Application:
29/020,522 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Apr 20, 2012
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RICKO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 028078/0320 →
Change of Name
Mar 24, 2014
From: IOMED, INC.
To: IOMED, LLC
Reel/Frame 032536/0225 →
Security Interest
May 7, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS THE COLLATERAL AGENT
Reel/Frame 035614/0001 →
Security Agreement
May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 035707/0454 →
Release of Security Interest
May 18, 2015
From: CREDIT SUISSE AG, AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 035706/0497 →
Security Agreement
May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.
To: THE BANK OF NEW YORK MELLON, AS THIRD LIEN AGENT
Reel/Frame 035707/0498 →
Release of Security Interest
May 18, 2015
From: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC; EMPI, INC.
Reel/Frame 035706/0457 →
Security Agreement
May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.
To: MACQUARIE US TRADING LLC, AS COLLATERAL AGENT
Reel/Frame 035707/0398 →
Release of Security Interest
Mar 14, 2019
From: MACQUARIE US TRADING LLC AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION
Reel/Frame 048655/0067 →
Release of Security Interest
Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION
Reel/Frame 050129/0262 →
Release of Security Interest
Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS THIRD LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION
Reel/Frame 048608/0932 →
Release of Security Interest
Mar 21, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION
Reel/Frame 048672/0661 →